[1]
P. Krawczyk, “THE EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR THERAPY IN THE TREATMENT OF HCV INFECTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE – A REVIEW OF CURRENT LITERATURE”, IJITSS, vol. 1, no. 2(50), May 2026, doi: 10.31435/ijitss.2(50).2026.5234.